Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “For Donors”

1,262 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,262 results

Testing effectiveness (Phase 2)UnknownNCT00907036
What this trial is testing

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 49
Not applicableUnknownNCT03759535
What this trial is testing

Study in Detection cfDNA for the Early-stage Diagnosis of Acute Rejection Post-renal Transplantation

Who this might be right for
Kidney Transplant Failure and Rejection
RenJi Hospital 60
Not applicableStudy completedNCT06437990
What this trial is testing

Arteriovenous Loop Graft for Free Functional Gracilis Transfer in Brachial Plexus Surgery

Who this might be right for
Brachial Plexus Injury
Siriraj Hospital 10
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Not applicableStudy completedNCT05255445
What this trial is testing

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

Who this might be right for
Sickle Cell DiseaseThalassemiaPediatric Cancer
Westat 157
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Very early researchEnded earlyNCT03705637
What this trial is testing

Liposomal Bupivicaine for Skin Graft Donor Sites in Burn Patients

Who this might be right for
BurnsPostoperative Pain
Massachusetts General Hospital 6
Post-approval studies (Phase 4)WithdrawnNCT02757287
What this trial is testing

Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors

Who this might be right for
Infertility
Fundacion Dexeus
Testing effectiveness (Phase 2)Study completedNCT00096096
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT05431361
What this trial is testing

PRehab tO PreparE Living Liver Donors for Enhanced Recovery

Who this might be right for
Living Donor Liver Transplantation
University Health Network, Toronto 30
Early research (Phase 1)Study completedNCT00005946
What this trial is testing

Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Early research (Phase 1)WithdrawnNCT05487495
What this trial is testing

Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoma
Beijing Boren Hospital
Testing effectiveness (Phase 2)UnknownNCT02568241
What this trial is testing

Interferon-α After DLI for the Prevention of Relapse

Who this might be right for
Leukemia
Peking University People's Hospital 42
Very early researchNot Yet RecruitingNCT07706205
What this trial is testing

Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) as Conditioning Regimen for ABO-incompatible Living Donor Kidney Transplantation

Who this might be right for
ABO Blood Type Incompatible Kidney Transplantation
West China Hospital 20
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Not applicableStudy completedNCT01911286
What this trial is testing

Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain in Potentiel Organ Donors.

Who this might be right for
Alternative Method of Apnea Test
Poitiers University Hospital 208
Not applicableUnknownNCT06039839
What this trial is testing

Using of Collagen Matrix for Maxillary Tuberosity Donor Area Preservation

Who this might be right for
Soft Tissue Atrophy
I.M. Sechenov First Moscow State Medical University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05316701
What this trial is testing

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+4 more
Orca Biosystems, Inc. 187
Testing effectiveness (Phase 2)UnknownNCT01894477
What this trial is testing

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionChronic Myelomonocytic LeukemiaMinimal Residual Disease+3 more
Fred Hutchinson Cancer Center 102
Not applicableUnknownNCT04518332
What this trial is testing

Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.

Who this might be right for
Pediatric Liver TransplantationDevelopmental DelayPostoperative Complications+1 more
RenJi Hospital 123
Next Page